The OCRF becomes a global partner in leading international ovarian cancer forum 

This month the OCRF will join the 15th Helene Harris Memorial Trust International (HHMT) forum as an invited Global Partner. The unique forum is run by Ovarian Cancer Action UK aims to drive progress by facilitating collaboration between leading ovarian cancer researchers and funders with a shared purpose. This is the first time international organisations have been invited to participate as Global Partners. The other partners are Ovarian Cancer Research Alliance (USA) and Ovarian Cancer Canada.  

Held every four years, this year’s HHMT forum will take place in Surrey, UK. The invitation-only event brings together leaders and researchers from around the world to discuss and debate cutting-edge research, share knowledge advances, inspire innovations and develop strategies to expedite meaningful progress for the global ovarian cancer community.  

The OCRF’s CEO Robin Penty will attend to contribute perspectives from the OCRF and our Australian ovarian cancer community and meet with the CEOs of our international counterparts. The 45 delegates will include leading researchers from across the globe. The OCRF’s Research Advisor, Dr Amy Wilson, along with OCRF-sponsored delegates Associate Professor Jason Lee, Queensland Institute of Medical Research Berghofer, and clinician researcher Dr Nikki Burdett, Peter MacCallum Cancer Centre and the University of Melbourne, will attend scientific sessions examining prevention, early detection, immunotherapies, resistant disease and new treatment approaches.  

Importantly, the HHMT forum is focused on turning robust discussion into action. Researchers on the ground will develop, and make public, a tangible roadmap of recommendations and collective priorities aimed at addressing the most common and aggressive form of ovarian cancer, high-grade serous.  

For over four decades, this important forum and the collaboration it fosters, has honoured the legacy of Helene Harris whose life was sadly claimed by ovarian cancer. Her family established HHMT International Forums to ensure that the best global experts work together to accelerate solutions for this insidious disease.